https://doi.org/10.4081/monaldi.2017.766
A case of obstructive sleep apnea syndrome associated with floppy eyelid syndrome: positive effect of CPAP therapy
Accepted: December 11, 2016
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The obstructive sleep apnoea syndrome (OSAS) may be associated with several eyes disorders, among which the most common is the floppy eyelid syndrome (FES). We intended to highlight the association between OSAS and FES and evaluate the effect of FES treatment with Continuous Positive Airway Pressure (CPAP). A 50-year patient with a 10-year history of snoring, sleep fragmentation and daytime sleepiness associated with several comorbidities has been studied. For six months, several ocular symptoms were present, particularly on waking up in the morning. An overnight respiratory polygraphy was performed at baseline and after CPAP titration. The treatment with CPAP corrects apnea/hypopnea events and rapidly improves patient’s daytime sleepiness and eyes FES-related symptoms. This improvement is already evident after a very short period of treatment.
Â
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Jyoti Kumari, Manish Advani, Gopal Purohit, Prevalence of pulmonary hypertension in chronic simple silicosis patients and its correlation with smoking history, occupation type, age and duration of silica exposure , Monaldi Archives for Chest Disease: Early Access
- Amos Lal, Ajay Kumar Mishra, Jamal Akhtar, Christoph Nabzdyk, Pneumothorax and pneumomediastinum in COVID-19 acute respiratory distress syndrome , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Anastasiia Russkikh, Oleksandr Korotych, Yuliia Sereda, Anastasia Samoilova, Jay Achar, Askar Yedilbayev, Masoud Dara, Irina Vasilyeva, Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Kamal Kant Sahu, Ajay Kumar Mishra, Amos Lal, COVID-2019: update on epidemiology, disease spread and management , Monaldi Archives for Chest Disease: Vol. 90 No. 1 (2020)
- Malay Sarkar, Irappa Madabhavi, SARS-CoV-2 variants of concern: a review , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
- Valeriu Plesca, Ana Ciobanu, Yuliia Sereda, Andrei Dadu, Do catastrophic costs impact treatment outcomes in people with rifampicin-resistant tuberculosis in the Republic of Moldova? , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Manuel Monti, Management of severe Falciparum malaria on a mission: A case report , Monaldi Archives for Chest Disease: Vol. 89 No. 1 (2019)
- Angelo Carretta, Paola Ciriaco, Alessandro Bandiera, Piergiorgio Muriana, Gianluigi Arrigoni, Giampiero Negri, Therapeutic strategy for tracheal chondrosarcoma: report of two cases , Monaldi Archives for Chest Disease: Vol. 90 No. 1 (2020)
- Shekhar Kunal, Kashish Gupta, Shashi Mohan Sharma, Vijay Pathak, Shruti Mittal, Chandrakant Tarke, Cardiovascular system and COVID-19: perspectives from a developing country , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Kartik Deshmukh, Arjun Khanna, Single inhaler triple therapy in COPD – all that glitters is not gold , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
<< < 42 43 44 45 46 47 48 49 50 51 > >>
You may also start an advanced similarity search for this article.
